Biotech Startups

Labcyte developed acoustic droplet ejection ("Echo") liquid-handling instruments that use focused sound waves to transfer nanoliter-scale liquid volumes between microplates without physical contact. Its technology served drug discovery, genomics, and proteomics workflows in pharma, biotech, and academic labs.

2 investors

Labomar is a company involved in food production and research, participating in the Food-4-Life research project focused on improving plant and animal raw materials for functional foods with high nutritional value while maintaining ecological sustainability.

2 investors

Lactiga is a biotechnology company developing mucosal antibody therapies based on secretory IgA antibodies derived from human breastmilk. Its platform targets conditions such as chronic respiratory disorders, gut inflammation, and immune deficiencies through mucosal immunotherapy.

2 investors

Lakeshore Biopharma (Nasdaq: LSB, formerly Yisheng Biopharma) is a biopharmaceutical company focused on developing, producing, and selling vaccines and immunological products for infectious diseases. Its main marketed product is a lyophilized human rabies vaccine (Vero cell), and it uses a proprietary PIKA immunomodulating technology.

2 investors

Lamin provides a lineage-native lakehouse platform for biological R&D that enables scientists to query, trace, and validate complex biological datasets across academia, biotech, and pharma. The platform integrates data versioning and cataloging capabilities to close the feedback loop between experimental results and machine learning models.

2 investors

LASE Innovation provides single-cell tracking and barcoding technology that captures time-dimension data to train AI/ML models for biological research. The company commercializes optical cell barcoding developed at Massachusetts General Hospital and MIT, enabling researchers to track millions of cells across time and conditions.

2 investors

Lassogen engineers lasso peptides — structurally unique 3D scaffolds — into therapeutics it calls Lassotides, designed to combine the strengths of antibodies and small molecules. The company develops these therapeutics to treat challenging diseases and disease targets inadequately addressed by existing approaches.

2 investors

LastMinute automates healthcare scheduling using AI and predictive analytics to optimize staffing levels for nurses and healthcare facilities. The platform addresses workforce management challenges in the healthcare industry.

2 investors

Latus develops gene therapy research and development capabilities leveraging cell and gene therapy expertise. The company operates from Philadelphia and Boston, serving the biotechnology and therapeutics industry.

2 investors

Lazarus 3D uses a patented soft-tissue 3D printing process to produce anatomically accurate, operable surgical models that let surgeons rehearse patient-specific procedures before operating. The company serves hospitals, surgeons, and healthcare administrators in the medical/surgical rehearsal space.

2 investors

Lazzaro Medical develops a minimally invasive robotic surgery for repairing tracheobronchomalacia (TBM), a degenerative airway disease, using an implantable scaffold system as an alternative to risky open surgery. Its offering also includes diagnostic tools and surgical training programs for hospitals, thoracic surgeons, otolaryngologists, and pulmonologists.

2 investors

Lead Pharma develops small-molecule therapies targeting autoimmune disease, metabolic disease, and cancer. The company serves patients in need of innovative pharmaceutical treatments.

2 investors

Leal Therapeutics is a company focused on CNS (central nervous system) disorders, drawing on academic and drug-development experience in neurology and neurodegenerative disease.

2 investors

Leash Bio is a biotech company developing AI-driven drug discovery tools, combining molecular chemistry expertise with machine learning to accelerate research workflows for pharma and biotech organizations.

2 investors

Legend Biotech is a biotechnology company. The provided page content is an external-link disclaimer and contains no substantive information about the company's products or business.

2 investors

Leica Microsystems manufactures optical microscopy instruments and fluorescence reagents for scientific research and diagnostics. The company serves laboratories, research institutions, and diagnostic facilities requiring advanced imaging and analytical equipment.

2 investors

Lemnisca Bio builds AI-native digital twins ("flight simulators") that model bioprocess behavior using machine learning combined with metabolic and reactor physics rules, helping make precision fermentation and biomanufacturing predictable and scalable. The platform supports R&D recipe discovery, scale-up guidance, and real-time manufacturing control for bioprocess and biotech producers.

2 investors

Lentitek develops an alternative lentiviral vector production platform based on novel synthetic promoter technology, aimed at improving quality and yield in CAR-T manufacture and enabling in-vivo and armoured CAR applications. It works with advanced therapy (ATMP) asset developers through a serviced CRO license model to integrate and validate its vector solution.

2 investors

Lepidext develops a biocontrol product based on a naturally-occurring corn earworm virus isolate that increases sterility in infected insects, aimed at controlling corn earworm in agricultural crops. The company holds a patent on the isolate and has submitted an EPA registration application ahead of commercialization.

2 investors

Lever Bio develops immunotherapy drug candidates in immuno-oncology, partnering with top researchers and academic institutions to translate discoveries into cancer immunotherapies. The company is focused on in-licensing and advancing promising programs from discovery through preclinical and clinical development stages.

2 investors

Levicept is a company in the life sciences sector with backing from prominent healthcare and pharmaceutical investors including Medicxi, Pfizer Ventures, Gilde Healthcare, and Advent Life Sciences.

2 investors

Lexeo is a clinical-stage genetic medicine company developing gene therapies that target the genetic causes of cardiovascular diseases. Based in New York City, it focuses on treatments for heart health and other genetic diseases regardless of prevalence.

2 investors

Liberation Bioindustries provides a platform for rapid deployment of biomanufacturing capacity using precision fermentation for companies developing bio-based products.

2 investors

Liberum develops cell-free protein expression systems spanning bacterial, yeast, insect and mammalian biology, turning generated sequences into physical proteins and measured data. Its infrastructure serves AI labs, cloud labs, and protein discovery and engineering workflows including directed evolution, antibody production, and vaccine antigen manufacturing.

2 investors